CSW-A TOR Week ended 31 Jul 2026

Weekly Investor Report

Corby Spirit and Wine Limited · Consumer Defensive · Beverages - Wineries & Distilleries

Open interactive chart View report data
Latest close 16.32 CAD
3.0% latest week
Weekly setup

Constructive trend

The weekly trend is active. Price is 10.8% above the Trend Line and sits at 87.6% of its 52-week range. The latest completed week returned 3.0%, after a 2.4% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 66/100.

Setup score 77 out of 100
Latest Close 16.32 CAD 31 Jul 2026
1W Return 3.0% latest completed week
4W Return 2.4% short-term follow-through
12W Return 7.7% quarterly tape
Trend Breadth 84.6% 44 of 52 weeks active
Volume Ratio 2.6x vs 13-week average
What is working
  • The trend backdrop is active with a 36-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 3 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.0% Latest completed week; four-week move 2.4%. Indicator stack 92/74 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 66/100 2 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 10.8% above the Trend Line and sits at 87.6% of its 52-week range. The latest completed week returned 3.0%, after a 2.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9712-week average 0.95

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.97Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 2.4% over four weeks, 7.7% over 12 weeks, and 19.7% over one year. The current trend has remained active for 36 consecutive weeks.

Performance by holding period

1W3.0%
4W2.4%
12W7.7%
26W21.5%
52W19.7%
Active trend streak36 weeks
Active weeks in one year44
Trend breadth84.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.31Latest activity-pressure read.
Pressure change5.1%Four-week change in activity pressure.
Leadership4.50Latest relative-leadership reading.
RS change275.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength86/100Blend of value, momentum, and quality. Underlying universe rank 15; rank 1 is best.
Value80/100Relative valuation strength. Underlying universe rank 21; rank 1 is best.
Quality90/100Profitability and accounting quality. Underlying universe rank 11; rank 1 is best.
Momentum31/100Medium-term price momentum. Underlying universe rank 70; rank 1 is best.
Growth69/100Revenue and earnings growth. Underlying universe rank 32; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework84/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
13.6x
Price divided by trailing earnings.
Price / sales
1.7x
Market value relative to trailing revenue.
EV / EBITDA
8.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
48.6%
Gross profit retained from each unit of revenue.
Operating margin
19.2%
Operating profit retained from revenue.
Free-cash-flow margin
12.0%
Free cash flow generated from revenue.
Return on invested capital
13.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
7.5%
Latest one-year revenue growth.
EPS growth
14.7%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
49.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
5.9%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
5.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment66/100

Weighted news tone is positive across 2 relevant articles.

1 positive · 1 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.0%Distance below the 52-week high.
13-week volatility1.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+4.2%Week of 8 May.
Worst week-1.8%Week of 6 Mar.
Latest week+3.0%Week of 31 Jul.

Shape of recent returns

Strong gains1
Modest gains14
Flat weeks0
Modest losses11
Sharp losses0
Recent vol1.8%13-week weekly-return volatility.
Base vol2.0%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew2.0% / -1.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape79/100

Trend, activity pressure, participation, and risk combine to a 79/100 tape read.

 Indicator analysis74/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 5/12.

Activity pressure 0.97; 3 reversal markers Factors73/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 55; Small Cap Core rank 26 SVQF84/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 48.5 of 298 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment66/100

Weighted news tone is positive across 2 relevant articles.

Corby Spirit and Wine Ltd (CBYDF) Q3 2026 Earnings Call Highlights: Record Revenue Amid Market ... Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202616.32 CAD3.0%14.73 CAD12.73 CAD1.314.50173.4KOn
24 Jul 202615.84 CAD1.0%14.66 CAD12.70 CAD1.310.8389.1KOn
17 Jul 202615.68 CAD-0.4%14.60 CAD12.69 CAD1.26-0.0845.7KOn
10 Jul 202615.75 CAD-1.2%14.53 CAD12.67 CAD1.280.0859.9KOn
3 Jul 202615.94 CAD-0.6%14.45 CAD12.64 CAD1.251.2072.3KOn
26 Jun 202616.04 CAD2.8%14.38 CAD12.62 CAD1.052.4220.6KOn
19 Jun 202615.60 CAD2.1%14.32 CAD12.59 CAD1.10-0.504.1KOn
12 Jun 202615.28 CAD2.5%14.26 CAD12.56 CAD1.15-2.6722.4KOn
5 Jun 202614.91 CAD-0.8%14.21 CAD12.54 CAD1.17-3.822.9KOn
29 May 202615.03 CAD1.3%14.16 CAD12.52 CAD1.41-4.2897.6KOn
22 May 202614.83 CAD-1.2%14.10 CAD12.50 CAD1.28-4.9289.7KOn
15 May 202615.01 CAD-0.9%14.04 CAD12.48 CAD1.15-2.2252.0KOn
8 May 202615.15 CAD4.2%13.96 CAD12.46 CAD0.87-2.22126.4KOn
1 May 202614.54 CAD-0.7%13.89 CAD12.45 CAD0.45-6.0933.9KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.